These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10429986)

  • 21. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity.
    Ameglio F; D'Auria L; Bonifati C; Ferraro C; Mastroianni A; Giacalone B
    Br J Dermatol; 1998 Apr; 138(4):611-4. PubMed ID: 9640364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interleukin-2 receptor in lesions and serum of bullous pemphigoid.
    Zillikens D; Ambach A; Schuessler M; Dummer R; Hartmann AA; Burg G
    Arch Dermatol Res; 1992; 284(3):141-5. PubMed ID: 1503497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.
    Schmidt E; Bastian B; Dummer R; Tony HP; Bröcker EB; Zillikens D
    Arch Dermatol Res; 1996 Jun; 288(7):353-7. PubMed ID: 8818181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
    Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
    J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders.
    Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH;
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of tumor necrosis factor in blister fluids of bullous pemphigoid.
    Takematsu H; Ohta H; Tagami H
    Arch Dermatol Res; 1991; 283(2):131-2. PubMed ID: 2069411
    [No Abstract]   [Full Text] [Related]  

  • 27. Photo-induced toxic epidermal necrolysis caused by clobazam.
    Redondo P; Vicente J; España A; Subira ML; De Felipe I; Quintanilla E
    Br J Dermatol; 1996 Dec; 135(6):999-1002. PubMed ID: 8977728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leukotriene (LT) B4 and LTC4 in the blister fluid of bullous pemphigoid].
    Kawana S; Nishiyama S
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):659-64. PubMed ID: 2555604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Localized bullous pemphigoid induced by thermal burn].
    Vermeulen C; Janier M; Panse I; Daniel F
    Ann Dermatol Venereol; 2000; 127(8-9):720-2. PubMed ID: 11011162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blister fluid composition in a pediatric patient with toxic epidermal necrolysis.
    Gandhi M; Kowal-Vern A; An G; Hanumadass M
    J Burn Care Res; 2008; 29(4):671-5. PubMed ID: 18535474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis.
    Paquet P; Ribbens C; Piérard GE
    Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
    D'Auria L; Pietravalle M; Cordiali-Fei P; Ameglio F
    Exp Dermatol; 2000 Apr; 9(2):131-7. PubMed ID: 10772387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.
    Le Jan S; Plée J; Vallerand D; Dupont A; Delanez E; Durlach A; Jackson PL; Edwin Blalock J; Bernard P; Antonicelli F
    J Invest Dermatol; 2014 Dec; 134(12):2908-2917. PubMed ID: 24945093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual bullous disorder with features of toxic epidermal necrolysis, bullous pemphigoid and cicatricial pemphigoid.
    Redondo P; España A; Idoate M; Sánchez-Ibarrola A; Quintanilla E
    Clin Exp Dermatol; 1995 Jan; 20(1):65-9. PubMed ID: 7671403
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytokine pattern in blister fluid and sera of patients with pemphigus.
    Baroni A; Perfetto B; Ruocco E; Greco R; Criscuolo D; Ruocco V
    Dermatology; 2002; 205(2):116-21. PubMed ID: 12218224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophil-colony stimulating activity in blister fluid of bullous pemphigoid.
    Kawachi Y; Otsuka F
    J Dermatol Sci; 1997 May; 15(1):51-4. PubMed ID: 9186812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.
    Correia O; Delgado L; Roujeau JC; Le Cleach L; Fleming-Torrinha JA
    Arch Dermatol; 2002 Jan; 138(1):29-32. PubMed ID: 11790164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bullous pemphigoid--a scanning electron microscopic study.
    Ookusa Y; Takata K; Nagashima M; Hirano H
    Dermatologica; 1986; 172(1):6-11. PubMed ID: 3514299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis?
    Ludwig RJ; Schmidt E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):339-49. PubMed ID: 19755940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
    Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA
    Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.